#SynBioBeta

In full force at #SynBioBeta - come by for a free gait score! Learn about our TrackedGait Clinical™ and TrackedFlyBox™ systems

At #SynBioBeta, we showcased live demos of TrackedGait™ and the newest version of our revolutionary TrackedFlyBox™. From gait analysis to Drosophila research, our tools are designed to help scientists capture better data, faster.

Genyro’s Adrian Woolfson and Kaihang Wang said Sidewinder 2.0 assembled 24 DNA constructs at once from a single oligo pool, while pushing misconnection rates down from 1 in 1 million to 1 in 10 million. #SynBioBeta #Biotech

What if the biggest bottleneck in biology isn’t ideas — but measurement? @10xGenomics CEO Serge Saxonov is helping drive a revolution in single-cell and spatial biology that’s generating massive datasets for AI-driven discovery. Visit the #SynBioBeta website to read the full article:

Can humans finally live forever? Join Jason Kelly and Bryan Johnson take the main stage at #SynBioBeta to explore how synthetic biology might have the solution to the age code. Let’s have a telomere party-- Telomerases are NOT invited! @jrkelly @bryan_johnson 📅 May 8 | 11:40 AM | San Jose

The future of drug discovery is increasingly software-defined. AI infrastructure is powering the next wave of bio innovation. 🧬💻 See you at SynBioBeta — May 4–7, 2026 • San Jose 🌐 Register and join the conversation at SynBioBeta #SynBioBeta #Biomanufacturing #Engineering #StartupLife #SyntheticBiology

AI is speeding up DNA synthesis in ways that could reshape how biology gets built, tested, and scaled 🧬⚙️🚀 🧬 SynBioBeta • May 4–7, 2026 • San Jose Register and join the conversation at SynBioBeta #SynBioBeta #Biomanufacturing #Engineering #StartupLife #SyntheticBiology

@genentech principal scientist Susan Klaeger said cancer cells display over 3,500 previously unknown peptides on their surface, more than 20x what standard approaches detect, sharpening the case for protein sequencing as biology’s next frontier. #SynBioBeta #Biotech

@powbio’s Ouwei Wang said the company is already running autonomous bioreactors in Alameda, using an AI control layer screened through a digital twin so proposed actions are simulated before they ever reach the reactor. #SynBioBeta #Biotech

Having a spacesuit headshot is pretty damn cool 😃😃 Easy to forget that biology provides all our life support on earth. You remember when thinking about living on moon, mars, in orbit !! Lots of future opportunities for synthetic biology! #synbiobeta

Jason T. Gammack said @AnsaBio shipped 47 megabases of DNA, about 26,000 genes, with a 97.3% fulfillment rate as it expands clonal DNA up to 50 kb through @idtdna. #SynBioBeta #Biotech

At SynBioBeta, Jens Nielsen and Eduardo Abeliuk argued metabolic engineering is moving from mechanistic models toward an agentic layer, with some strain programs once costing $100M+ now achievable for $10M-$20M. #SynBioBeta #Biotech

Andrew Chang said the company can quantify more than 10 billion antibody-antigen interactions and their affinities in a single experiment, arguing that dynamic protein-protein interaction data is the missing layer for drug discovery. #SynBioBeta #Biotech

At SynBioBeta, @sanofi joined Latent Labs, Strand Therapeutics, and Magnet Ventures to frame a new class of context-aware therapeutics: medicines designed to stay inert until they encounter disease signals, then activate with precision. #SynBioBeta #Biotech

What better way to kick off the first day of #SynBioBeta than with a space legend? On May 5 (aka #AstronautDay 🚀) @NASA astronaut Kate Rubins will deliver a special welcome during our New Attendee Reception, 5PM at San Jose. Fun fact: Kate worked with George Church to sequence DNA from the space station! @Astro_Kate7 @geochurch

At SynBioBeta, Neil Parry said @Unilever has already launched a biotech-derived biosurfactant in seven markets and that it outperforms conventional surfactants, as @ArzedaCo, Gore, and MANE argued AI protein design is moving from concept to consumer products. #SynBioBeta #Biotech

Michael Clear of @schmidtsciences outlined three sensing platforms—fluorescent nanodiamonds, single-cell Raman spectroscopy, and dual-comb spectroscopy—designed to bring real-time physiological data into bioprocess monitoring. #SynBioBeta #Biotech

Our founder, @aitherick, will be at #SynBioBeta this week. If you're around and would like to connect on longevity / veterinary topics, reach out.

🧵As AI reshapes the future of drug discovery, pharma companies are rethinking what they need from early-stage partners. At #SynBioBeta, Cynthia Hong from @Novartis , @EliBerlin3 from Terray Therapeutics @Terray_Tx , Jakob Uszkoreit @kyosu from Inceptive, and @ola_wlodek from Constructive Bio @BioConstructiv, moderated by @Nima_Ronaghi from @breakout_vc Breakout Ventures, explored how pharma thinks about these partnerships. Here are some highlights if you weren't able to join the conversation.

Simon Kohl said Latent Labs’ Latent-X2 produced antibody formats that were already developable 47% of the time without optimization, as the company pushes antibody discovery from screening toward prompt-driven design. #SynBioBeta #Biotech